Article info

Download PDFPDF

Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC

Authors

  • Caroline Tosch Transgene SA 400 Bld Gonthier d’Andernach, Parc d’Innovation, CS80166 67405 Illkirch Graffenstaden Cedex France PubMed articlesGoogle scholar articles
  • Bérangère Bastien Transgene SA 400 Bld Gonthier d’Andernach, Parc d’Innovation, CS80166 67405 Illkirch Graffenstaden Cedex France PubMed articlesGoogle scholar articles
  • Luc Barraud Transgene SA 400 Bld Gonthier d’Andernach, Parc d’Innovation, CS80166 67405 Illkirch Graffenstaden Cedex France PubMed articlesGoogle scholar articles
  • Benoit Grellier Transgene SA 400 Bld Gonthier d’Andernach, Parc d’Innovation, CS80166 67405 Illkirch Graffenstaden Cedex France PubMed articlesGoogle scholar articles
  • Virginie Nourtier Transgene SA 400 Bld Gonthier d’Andernach, Parc d’Innovation, CS80166 67405 Illkirch Graffenstaden Cedex France PubMed articlesGoogle scholar articles
  • Murielle Gantzer Transgene SA 400 Bld Gonthier d’Andernach, Parc d’Innovation, CS80166 67405 Illkirch Graffenstaden Cedex France PubMed articlesGoogle scholar articles
  • Jean Marc Limacher Transgene SA 400 Bld Gonthier d’Andernach, Parc d’Innovation, CS80166 67405 Illkirch Graffenstaden Cedex France Current address: Department of Medical Oncology and Clinical HematologyLouis Pasteur Hospital 39 Av de la Liberté 68000 Colmar France PubMed articlesGoogle scholar articles
  • Eric Quemeneur Transgene SA 400 Bld Gonthier d’Andernach, Parc d’Innovation, CS80166 67405 Illkirch Graffenstaden Cedex France PubMed articlesGoogle scholar articles
  • Kaïdre Bendjama Transgene SA 400 Bld Gonthier d’Andernach, Parc d’Innovation, CS80166 67405 Illkirch Graffenstaden Cedex France PubMed articlesGoogle scholar articles
  • Xavier Préville Transgene SA 400 Bld Gonthier d’Andernach, Parc d’Innovation, CS80166 67405 Illkirch Graffenstaden Cedex France Current address: Amoneta Diagnostics 17 rue du Fort 68330 Huningue France PubMed articlesGoogle scholar articles
  1. a tosch{at}transgene.fr
  2. b bastien{at}transgene.fr
  3. c barraud{at}transgene.fr
  4. d grellier{at}transgene.fr
  5. e nourtier{at}transgene.fr
  6. f gantzer{at}transgene.fr
  7. g jean-marc.limacher{at}ch-colmar.fr
  8. h quemeneur{at}transgene.fr
  9. i bendjama{at}transgene.fr
  10. j xavier.preville{at}amoneta-diagnostics.com
View Full Text

Citation

Tosch C, Bastien B, Barraud L, et al
Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC

Publication history

  • Received May 6, 2017
  • Accepted August 11, 2017
  • First published September 19, 2017.
Online issue publication 
September 19, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.